Regulation of G protein function: Implications for heart disease
Heterotrimeric GTP-binding and -hydrolyzing proteins (G proteins) link members of a family of seven-helix transmembrane receptors (G protein-coupled receptors, GPCR) to intracellular effectors. The coupling mechanism involves the G protein completing a cycle of activation, dissociation into a and βγ subunits, deactivation, and reassociation. At the center of this cycle is the α subunit, in which activation by GPCR, GTPase activity, and regulation of effector are combined. Whereas Gα’s functional domains and residues had already been inferred from mutagenesis studies, the recent solution of the crystal structure has elucidated the structural basis of α subunit function. It is now clear that an irregularity in any GPCR pathway component could cause a physiological defect. This is confirmed by the identification of mutations in GPCR and Gα’s in various human diseases. Although several cardiomyopathies are associated with abnormal GPCR function, mutations are unlikely in these disorders. The last few years, other aspects of G protein function have moved into focus: e.g. posttranslational modifications; effector regulation by βγ subunits; GTPase activating protein (GAP) activity of effectors; G protein expression levels etc. When comparing the regulation of G protein functional activity in cAMP and in inositol phosphate generating pathways, an extrapolation can be made to data on the status of these pathways in some cardiovascular diseases.
Key wordsG protein adenylate cyclase phospholipase C GAP heart disease
G protein-coupled receptor
GTPase activating protein
Unable to display preview. Download preview PDF.
- 6.Linder ME, Ewald DA, Miller RJ, Gilman AG: Purification and charaterization of G0α and three types of Giα after expression in Escherichia coli. J Bioi Chem 265: 8243–8251, 1990Google Scholar
- 19.Tang, W-J., Gilman AG: Science, 1995 (in press)Google Scholar
- 26.Dixon IMC, Dhalla NS: Alterations in cardiac adrenoceptors in congestive heart failure secondary to myocardial infarction. Coronary Artery Disease 2: 805–814, 1991Google Scholar
- 39.Sethi R, Elimban V, Chapman D, Dixon IMC, Dhalla NS: Status of G-proteins in congestive heart failure due to myocardial infarction. J Mol Cell Cardiol 27: A59, 1995Google Scholar
- 40.Kawaguchi H, Shoki M, Sano H, Kudo T, Sawa H, Okamoto H, Sakata Y, Yasuda H: Phospholipid metabolism in cardiomyopathic hamster heart cells. Circ Res 69: 1015–1021, 1995Google Scholar
- 43.Ziegelhoffer A, Meij JTA, Panagia V, Jasmin G, Dhalla NS: Kinetic deviations of myocardial phosphoinositide-phospholipase C in cardiomyopathic hamsters (UM-X7.1) at advanced stage of congestive heart failure. Can J Cardiol 10: 108A, 1994Google Scholar